General Information of the Compound
| Compound ID |
CP0471072
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2R,3R)-2-(4-methoxyphenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H29F3N4O4
|
||||||||||||||||||
| Molecular Weight |
566.58
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(cc1)[C@@H]([C@@H](CCC(F)(F)F)C(=O)N[C@H]1N=C(c2ccccc2)c2ccccc2N(C)C1=O)C(N)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H29F3N4O4/c1-37-23-11-7-6-10-21(23)25(19-8-4-3-5-9-19)35-27(29(37)40)36-28(39)22(16-17-30(31,32)33)24(26(34)38)18-12-14-20(41-2)15-13-18/h3-15,22,24,27H,16-17H2,1-2H3,(H2,34,38)(H,36,39)/t22-,24+,27-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
MCIWNCZITHCVOD-RWCIVJTCSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04100, Neurogenic locus notch homolog protein 1
Protein ID: PT04261, Neurogenic locus notch homolog protein 3